Physician profile
Miranda E Prejean
NPI 1043552607
$607.95
in general payments reported to CMS, 2019-2025
10 companies · $14.13 in 2025
The $14.13 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $447 · 2022: $67.82 · 2023: $49.82 · 2024: $29.28 · 2025: $14.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $93.23.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $93.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $313.63 | 2021-2024 | |
| Novo Nordisk INC | $94.83 | 2021 | |
| Sunovion Pharmaceuticals INC. | $34.04 | 2021 | |
| Boston Scientific Corporation | $33.01 | 2023-2025 | General - Therapies |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.00 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $25.33 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $22.09 | 2021 | |
| Paratek Pharmaceuticals, INC. | $21.74 | 2021 | |
| Lilly USA, LLC | $17.66 | 2021 | |
| Amgen INC. | $15.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miranda Prejean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.